Brenes Robert A, Sobotka Lubos, Ajemian Michael S, Manak Jan, Vyroubal Pavel, Slemrova Miroslava, Adamkova Vladimira, Zajic Jiri, Dudrick Stanley J
The Stanley J. Dudrick Department of Surgery, St Mary's Hospital, 56 Franklin St, Waterbury, CT 06706, USA.
Arch Surg. 2011 Nov;146(11):1323-5. doi: 10.1001/archsurg.2011.272.
A wound-healing agent developed in the European Union is based on the combination of organic hyaluronan with inorganic iodine. The aim of this pilot study was to assess the efficacy and safety of hyaluronate-iodine in the treatment of sternal wounds. Eight patients with sternal wound dehiscence were entered into the study. After debridement, wounds were dressed with gauze soaked in hyaluronate-iodine. In one patient with an epipleural abscess, hyaluronate-iodine was instilled directly into the abscess cavity daily. Complete healing was achieved in 7 patients, and 1 patient underwent a reconstructive operation for wound closure. The mean (SD) length of treatment was 136 (114.2) days. No adverse effects or complications were apparent in this group. Hyaluronate-iodine is safe and effective in healing sternal wound dehiscence. Randomized controlled trials are needed for further validation.
欧盟研发的一种伤口愈合剂是基于有机透明质酸与无机碘的组合。这项初步研究的目的是评估透明质酸碘治疗胸骨伤口的疗效和安全性。八名胸骨伤口裂开的患者进入该研究。清创后,伤口用浸泡有透明质酸碘的纱布包扎。在一名患有胸膜上脓肿的患者中,每天将透明质酸碘直接注入脓肿腔。7名患者实现了完全愈合,1名患者接受了伤口闭合的重建手术。平均(标准差)治疗时长为136(114.2)天。该组未出现明显不良反应或并发症。透明质酸碘在愈合胸骨伤口裂开方面安全有效。需要进行随机对照试验以进一步验证。